Fig 3.
Correlation of Hsp72, anti-Hsp60 auto-antibodies, and IL-6 with left ventricular end-diastolic dimensions (LVEDD) values in the whole population of patients: group C (healthy controls), group N (LV ejection fraction [EF] ≥50%), group I (LVEF ≥35% to <50%) and group II (LVEF <35%)